{"id":23071,"date":"2024-03-12T10:42:57","date_gmt":"2024-03-12T09:42:57","guid":{"rendered":"https:\/\/ggba.swiss\/neuria-enters-vanguard-accelerator-to-gameify-healthier-lifestyles\/"},"modified":"2024-03-12T10:45:09","modified_gmt":"2024-03-12T09:45:09","slug":"neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/","title":{"rendered":"Neuria int\u00e8gre l&rsquo;acc\u00e9l\u00e9rateur Vanguard pour promouvoir des modes de vie plus sains"},"content":{"rendered":"\n<p>Bas\u00e9e \u00e0 Fribourg et n\u00e9e comme spin-off de l&rsquo;Universit\u00e9 de Fribourg, <a href=\"https:\/\/www.neuria.ch\/\">Neuria<\/a> est \u00e0 l&rsquo;origine d&rsquo;une plateforme visant \u00e0 transformer les comportements malsains, tels que les mauvaises habitudes alimentaires, l&rsquo;abus d&rsquo;alcool et le tabagisme, en changements de style de vie positifs. En exploitant la puissance des jeux interactifs qui int\u00e8grent un m\u00e9canisme neurocognitif brevet\u00e9, l&rsquo;approche innovante de Neuria fait des progr\u00e8s dans le domaine des th\u00e9rapies num\u00e9riques (DTx) et cherche maintenant \u00e0 \u00e9tendre son impact \u00e0 partir du campus du <a href=\"https:\/\/www.biopole.ch\/\">Biop\u00f4le<\/a>.<\/p>\n\n\n\n<p>Le jeu phare de la start-up, \u00ab&nbsp;The Diner&nbsp;\u00bb, a d\u00e9j\u00e0 montr\u00e9 des r\u00e9sultats remarquables, r\u00e9duisant les envies et la consommation r\u00e9elle d&rsquo;aliments malsains de 20 % chez les participants. Cette fusion du plaisir et de l&rsquo;am\u00e9lioration de la sant\u00e9 souligne non seulement le potentiel de la plateforme de Neuria \u00e0 r\u00e9volutionner la sant\u00e9 des patients, mais aussi le r\u00f4le des solutions innovantes dans la promotion de choix de vie plus sains.<\/p>\n\n\n\n<p>Frederik Plourde, cofondateur et CEO de Neuria, a exprim\u00e9 son enthousiasme quant \u00e0 la capacit\u00e9 du programme d&rsquo;acc\u00e9l\u00e9ration \u00e0 positionner Neuria en tant que leader de l&rsquo;industrie DTx en Suisse et \u00e0 attirer un solide consortium d&rsquo;investisseurs pour leur tour de financement d&rsquo;amor\u00e7age en cours. Lucas Spierer, cofondateur et CSO, a soulign\u00e9 l&rsquo;ambition de la start-up de transformer son innovation en un produit pr\u00eat \u00e0 \u00eatre commercialis\u00e9, en naviguant dans le paysage complexe des r\u00e9glementations m\u00e9dicales en Suisse et dans l&rsquo;UE.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Contribuer \u00e0 un avenir plus sain pour les individus dans le monde entier<\/h4>\n\n\n\n<p>Avec un MVP d\u00e9j\u00e0 en place d\u00e9montrant des r\u00e9ductions significatives de la consommation de sucre, les prochaines \u00e9tapes de Neuria consistent \u00e0 obtenir une licence de dispositif m\u00e9dical et \u00e0 lancer leur produit sur le march\u00e9. L&rsquo;\u00e9quipe s&rsquo;engage activement aupr\u00e8s de partenaires B2B pour des projets pilotes r\u00e9mun\u00e9r\u00e9s et est en train de lever CHF 1,2 million pour poursuivre sa mission.<\/p>\n\n\n\n<p>La participation de Neuria au programme <a href=\"https:\/\/www.biopole.ch\/start-ups\/vanguard\/\">Vanguard Accelerator<\/a> s&rsquo;aligne sur la mission de l&rsquo;acc\u00e9l\u00e9rateur qui consiste \u00e0 nourrir les start-ups de la sant\u00e9 num\u00e9rique gr\u00e2ce \u00e0 des conseils d&rsquo;experts et \u00e0 des opportunit\u00e9s de d\u00e9veloppement commercial. En tant que dernier ajout \u00e0 une liste de prestigieux b\u00e9n\u00e9ficiaires, Neuria est sur la voie d&rsquo;une croissance transformatrice, contribuant \u00e0 l&rsquo;objectif plus large de r\u00e9duire les co\u00fbts des soins de sant\u00e9 gr\u00e2ce \u00e0 des applications num\u00e9riques innovantes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.<\/p>\n","protected":false},"author":6,"featured_media":23068,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1180,1188,1141,1168],"class_list":["post-23071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-digital-health-fr-2","tag-healthcare-fr-2","tag-personalized-medicine-fr-2","tag-technology-park-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neuria int\u00e8gre l&#039;acc\u00e9l\u00e9rateur Vanguard du Biop\u00f4le | GGBa<\/title>\n<meta name=\"description\" content=\"Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neuria int\u00e8gre l&#039;acc\u00e9l\u00e9rateur Vanguard du Biop\u00f4le | GGBa\" \/>\n<meta property=\"og:description\" content=\"Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-12T09:42:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-12T09:45:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Neuria int\u00e8gre l&rsquo;acc\u00e9l\u00e9rateur Vanguard pour promouvoir des modes de vie plus sains\",\"datePublished\":\"2024-03-12T09:42:57+00:00\",\"dateModified\":\"2024-03-12T09:45:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\"},\"wordCount\":440,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg\",\"keywords\":[\"Digital Health\",\"Healthcare\",\"Personalized Medicine\",\"Technology Park\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\",\"name\":\"Neuria int\u00e8gre l'acc\u00e9l\u00e9rateur Vanguard du Biop\u00f4le | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg\",\"datePublished\":\"2024-03-12T09:42:57+00:00\",\"dateModified\":\"2024-03-12T09:45:09+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Neuria offre non seulement une solution prometteuse pour la modification du comportement, mais fournit \u00e9galement des services \u00e9tendus aux entreprises li\u00e9es \u00e0 la sant\u00e9 et \u00e0 la communaut\u00e9 scientifique. | \u00a9 Biop\u00f4le - Neuria\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neuria int\u00e8gre l&#8217;acc\u00e9l\u00e9rateur Vanguard pour promouvoir des modes de vie plus sains\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neuria int\u00e8gre l'acc\u00e9l\u00e9rateur Vanguard du Biop\u00f4le | GGBa","description":"Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/","og_locale":"fr_FR","og_type":"article","og_title":"Neuria int\u00e8gre l'acc\u00e9l\u00e9rateur Vanguard du Biop\u00f4le | GGBa","og_description":"Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.","og_url":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-03-12T09:42:57+00:00","article_modified_time":"2024-03-12T09:45:09+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Neuria int\u00e8gre l&rsquo;acc\u00e9l\u00e9rateur Vanguard pour promouvoir des modes de vie plus sains","datePublished":"2024-03-12T09:42:57+00:00","dateModified":"2024-03-12T09:45:09+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/"},"wordCount":440,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg","keywords":["Digital Health","Healthcare","Personalized Medicine","Technology Park"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/","url":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/","name":"Neuria int\u00e8gre l'acc\u00e9l\u00e9rateur Vanguard du Biop\u00f4le | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg","datePublished":"2024-03-12T09:42:57+00:00","dateModified":"2024-03-12T09:45:09+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Neuria Digital Therapeutics est la premi\u00e8re start-up de 2024 \u00e0 b\u00e9n\u00e9ficier du programme Vanguard Accelerator.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/Neuria-Vanguard-Biopole-1180x811-1.jpg","width":1180,"height":811,"caption":"Neuria offre non seulement une solution prometteuse pour la modification du comportement, mais fournit \u00e9galement des services \u00e9tendus aux entreprises li\u00e9es \u00e0 la sant\u00e9 et \u00e0 la communaut\u00e9 scientifique. | \u00a9 Biop\u00f4le - Neuria"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/neuria-integre-laccelerateur-vanguard-pour-promouvoir-des-modes-de-vie-plus-sains\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Neuria int\u00e8gre l&#8217;acc\u00e9l\u00e9rateur Vanguard pour promouvoir des modes de vie plus sains"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=23071"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23071\/revisions"}],"predecessor-version":[{"id":23073,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23071\/revisions\/23073"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/23068"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=23071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=23071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=23071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}